FDA termination patient communication – Clinical Research Made Simple

Patient Notification and Follow-up Obligations After Early Termination

October 15, 2025

Patient Notification and Follow-up Obligations After Early Termination Patient Notification and Follow-up Obligations After Early Termination Introduction: Why Participant Communication is Essential When a clinical trial is terminated early, sponsors have a dual responsibility: to notify participants promptly and to ensure appropriate follow-up care. Regulatory agencies such as the FDA, EMA, and ICH E6 (R2)…

Interim Analysis and Trial Termination, Reporting of Early Termination to Regulators